nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolterodine—CYP2D6—Fingolimod—multiple sclerosis	0.135	0.203	CbGbCtD
Tolterodine—CYP3A4—Fingolimod—multiple sclerosis	0.0859	0.129	CbGbCtD
Tolterodine—CYP2C19—Prednisone—multiple sclerosis	0.0694	0.104	CbGbCtD
Tolterodine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0554	0.0831	CbGbCtD
Tolterodine—CYP2C19—Dexamethasone—multiple sclerosis	0.0433	0.065	CbGbCtD
Tolterodine—CYP3A4—Triamcinolone—multiple sclerosis	0.042	0.063	CbGbCtD
Tolterodine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0404	0.0606	CbGbCtD
Tolterodine—CYP2C9—Dexamethasone—multiple sclerosis	0.036	0.054	CbGbCtD
Tolterodine—CYP3A4—Betamethasone—multiple sclerosis	0.036	0.054	CbGbCtD
Tolterodine—CYP3A4—Prednisolone—multiple sclerosis	0.0355	0.0533	CbGbCtD
Tolterodine—CYP3A4—Prednisone—multiple sclerosis	0.0335	0.0503	CbGbCtD
Tolterodine—CYP2D6—Dexamethasone—multiple sclerosis	0.0329	0.0494	CbGbCtD
Tolterodine—CYP3A4—Dexamethasone—multiple sclerosis	0.0209	0.0314	CbGbCtD
Tolterodine—Bronchitis—Fingolimod—multiple sclerosis	0.00422	0.0199	CcSEcCtD
Tolterodine—Dementia—Prednisone—multiple sclerosis	0.00379	0.0178	CcSEcCtD
Tolterodine—Sinusitis—Fingolimod—multiple sclerosis	0.00367	0.0173	CcSEcCtD
Tolterodine—Disorientation—Cladribine—multiple sclerosis	0.00322	0.0151	CcSEcCtD
Tolterodine—Dementia—Methotrexate—multiple sclerosis	0.00317	0.0149	CcSEcCtD
Tolterodine—Delusion—Methylprednisolone—multiple sclerosis	0.00277	0.0131	CcSEcCtD
Tolterodine—Palpitations—Fingolimod—multiple sclerosis	0.0027	0.0127	CcSEcCtD
Tolterodine—Delusion—Betamethasone—multiple sclerosis	0.00252	0.0119	CcSEcCtD
Tolterodine—Delusion—Dexamethasone—multiple sclerosis	0.00252	0.0119	CcSEcCtD
Tolterodine—Infection—Fingolimod—multiple sclerosis	0.00248	0.0117	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Cladribine—multiple sclerosis	0.00231	0.0109	CcSEcCtD
Tolterodine—Delusion—Prednisone—multiple sclerosis	0.0022	0.0103	CcSEcCtD
Tolterodine—Urinary tract infection—Cladribine—multiple sclerosis	0.00216	0.0102	CcSEcCtD
Tolterodine—Fatigue—Fingolimod—multiple sclerosis	0.00215	0.0101	CcSEcCtD
Tolterodine—Memory impairment—Prednisone—multiple sclerosis	0.00198	0.00932	CcSEcCtD
Tolterodine—Oedema peripheral—Cladribine—multiple sclerosis	0.00196	0.00924	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Mitoxantrone—multiple sclerosis	0.00196	0.0092	CcSEcCtD
Tolterodine—Asthenia—Fingolimod—multiple sclerosis	0.00179	0.00843	CcSEcCtD
Tolterodine—Flatulence—Cladribine—multiple sclerosis	0.00171	0.00804	CcSEcCtD
Tolterodine—Diarrhoea—Fingolimod—multiple sclerosis	0.00171	0.00804	CcSEcCtD
Tolterodine—Dizziness—Fingolimod—multiple sclerosis	0.00165	0.00777	CcSEcCtD
Tolterodine—Dry eye—Betamethasone—multiple sclerosis	0.00165	0.00776	CcSEcCtD
Tolterodine—Dry eye—Dexamethasone—multiple sclerosis	0.00165	0.00776	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Prednisolone—multiple sclerosis	0.0016	0.00755	CcSEcCtD
Tolterodine—Headache—Fingolimod—multiple sclerosis	0.00156	0.00736	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Mitoxantrone—multiple sclerosis	0.00152	0.00716	CcSEcCtD
Tolterodine—Weight increased—Mitoxantrone—multiple sclerosis	0.00149	0.00701	CcSEcCtD
Tolterodine—Chest pain—Cladribine—multiple sclerosis	0.00148	0.00695	CcSEcCtD
Tolterodine—Arthralgia—Cladribine—multiple sclerosis	0.00148	0.00695	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Triamcinolone—multiple sclerosis	0.00148	0.00694	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Methylprednisolone—multiple sclerosis	0.00147	0.00693	CcSEcCtD
Tolterodine—Anxiety—Cladribine—multiple sclerosis	0.00147	0.00692	CcSEcCtD
Tolterodine—Confusional state—Cladribine—multiple sclerosis	0.00143	0.00672	CcSEcCtD
Tolterodine—Dry skin—Prednisolone—multiple sclerosis	0.00142	0.0067	CcSEcCtD
Tolterodine—Urinary tract infection—Mitoxantrone—multiple sclerosis	0.00142	0.00667	CcSEcCtD
Tolterodine—Oedema—Cladribine—multiple sclerosis	0.00142	0.00666	CcSEcCtD
Tolterodine—Infection—Cladribine—multiple sclerosis	0.00141	0.00662	CcSEcCtD
Tolterodine—Tachycardia—Cladribine—multiple sclerosis	0.00138	0.0065	CcSEcCtD
Tolterodine—Sinusitis—Mitoxantrone—multiple sclerosis	0.00137	0.00644	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Betamethasone—multiple sclerosis	0.00134	0.0063	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Dexamethasone—multiple sclerosis	0.00134	0.0063	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Cladribine—multiple sclerosis	0.00129	0.00607	CcSEcCtD
Tolterodine—Somnolence—Cladribine—multiple sclerosis	0.00126	0.00592	CcSEcCtD
Tolterodine—Weight increased—Prednisolone—multiple sclerosis	0.00122	0.00575	CcSEcCtD
Tolterodine—Fatigue—Cladribine—multiple sclerosis	0.00122	0.00574	CcSEcCtD
Tolterodine—Pain—Cladribine—multiple sclerosis	0.00121	0.0057	CcSEcCtD
Tolterodine—Constipation—Cladribine—multiple sclerosis	0.00121	0.0057	CcSEcCtD
Tolterodine—Arthralgia—Azathioprine—multiple sclerosis	0.0012	0.00565	CcSEcCtD
Tolterodine—Dry skin—Dexamethasone—multiple sclerosis	0.00119	0.00559	CcSEcCtD
Tolterodine—Dry skin—Betamethasone—multiple sclerosis	0.00119	0.00559	CcSEcCtD
Tolterodine—Bronchitis—Triamcinolone—multiple sclerosis	0.00119	0.00559	CcSEcCtD
Tolterodine—Feeling abnormal—Cladribine—multiple sclerosis	0.00117	0.00549	CcSEcCtD
Tolterodine—Gastrointestinal pain—Cladribine—multiple sclerosis	0.00116	0.00545	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Triamcinolone—multiple sclerosis	0.00115	0.0054	CcSEcCtD
Tolterodine—Infection—Azathioprine—multiple sclerosis	0.00114	0.00538	CcSEcCtD
Tolterodine—Weight increased—Triamcinolone—multiple sclerosis	0.00112	0.00529	CcSEcCtD
Tolterodine—Weight increased—Methylprednisolone—multiple sclerosis	0.00112	0.00527	CcSEcCtD
Tolterodine—Abdominal pain—Cladribine—multiple sclerosis	0.00112	0.00527	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.00105	0.00493	CcSEcCtD
Tolterodine—Hypersensitivity—Cladribine—multiple sclerosis	0.00104	0.00491	CcSEcCtD
Tolterodine—Visual impairment—Prednisolone—multiple sclerosis	0.00104	0.00487	CcSEcCtD
Tolterodine—Dry skin—Prednisone—multiple sclerosis	0.00103	0.00487	CcSEcCtD
Tolterodine—Weight increased—Dexamethasone—multiple sclerosis	0.00102	0.0048	CcSEcCtD
Tolterodine—Weight increased—Betamethasone—multiple sclerosis	0.00102	0.0048	CcSEcCtD
Tolterodine—Asthenia—Cladribine—multiple sclerosis	0.00102	0.00478	CcSEcCtD
Tolterodine—Hallucination—Methylprednisolone—multiple sclerosis	0.000981	0.00462	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Methotrexate—multiple sclerosis	0.000974	0.00459	CcSEcCtD
Tolterodine—Chest pain—Mitoxantrone—multiple sclerosis	0.00097	0.00457	CcSEcCtD
Tolterodine—Arthralgia—Mitoxantrone—multiple sclerosis	0.00097	0.00457	CcSEcCtD
Tolterodine—Diarrhoea—Cladribine—multiple sclerosis	0.000968	0.00456	CcSEcCtD
Tolterodine—Anxiety—Mitoxantrone—multiple sclerosis	0.000967	0.00455	CcSEcCtD
Tolterodine—Visual impairment—Methylprednisolone—multiple sclerosis	0.00095	0.00447	CcSEcCtD
Tolterodine—Feeling abnormal—Azathioprine—multiple sclerosis	0.000948	0.00446	CcSEcCtD
Tolterodine—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000941	0.00443	CcSEcCtD
Tolterodine—Confusional state—Mitoxantrone—multiple sclerosis	0.000938	0.00441	CcSEcCtD
Tolterodine—Dizziness—Cladribine—multiple sclerosis	0.000936	0.0044	CcSEcCtD
Tolterodine—Oedema—Mitoxantrone—multiple sclerosis	0.00093	0.00438	CcSEcCtD
Tolterodine—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.00093	0.00438	CcSEcCtD
Tolterodine—Infection—Mitoxantrone—multiple sclerosis	0.000924	0.00435	CcSEcCtD
Tolterodine—Abdominal pain—Azathioprine—multiple sclerosis	0.00091	0.00428	CcSEcCtD
Tolterodine—Tachycardia—Mitoxantrone—multiple sclerosis	0.000908	0.00427	CcSEcCtD
Tolterodine—Hallucination—Dexamethasone—multiple sclerosis	0.000892	0.0042	CcSEcCtD
Tolterodine—Hallucination—Betamethasone—multiple sclerosis	0.000892	0.0042	CcSEcCtD
Tolterodine—Weight increased—Prednisone—multiple sclerosis	0.000887	0.00418	CcSEcCtD
Tolterodine—Headache—Cladribine—multiple sclerosis	0.000886	0.00417	CcSEcCtD
Tolterodine—Visual impairment—Betamethasone—multiple sclerosis	0.000864	0.00407	CcSEcCtD
Tolterodine—Visual impairment—Dexamethasone—multiple sclerosis	0.000864	0.00407	CcSEcCtD
Tolterodine—Angioedema—Prednisolone—multiple sclerosis	0.000854	0.00402	CcSEcCtD
Tolterodine—Hypersensitivity—Azathioprine—multiple sclerosis	0.000848	0.00399	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000847	0.00399	CcSEcCtD
Tolterodine—Vertigo—Prednisolone—multiple sclerosis	0.00084	0.00395	CcSEcCtD
Tolterodine—Somnolence—Mitoxantrone—multiple sclerosis	0.000827	0.00389	CcSEcCtD
Tolterodine—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000819	0.00385	CcSEcCtD
Tolterodine—Fatigue—Mitoxantrone—multiple sclerosis	0.000802	0.00377	CcSEcCtD
Tolterodine—Pain—Mitoxantrone—multiple sclerosis	0.000795	0.00374	CcSEcCtD
Tolterodine—Constipation—Mitoxantrone—multiple sclerosis	0.000795	0.00374	CcSEcCtD
Tolterodine—Diarrhoea—Azathioprine—multiple sclerosis	0.000787	0.00371	CcSEcCtD
Tolterodine—Angioedema—Triamcinolone—multiple sclerosis	0.000786	0.0037	CcSEcCtD
Tolterodine—Angioedema—Methylprednisolone—multiple sclerosis	0.000784	0.00369	CcSEcCtD
Tolterodine—Hallucination—Prednisone—multiple sclerosis	0.000777	0.00366	CcSEcCtD
Tolterodine—Vertigo—Triamcinolone—multiple sclerosis	0.000773	0.00364	CcSEcCtD
Tolterodine—Vertigo—Methylprednisolone—multiple sclerosis	0.000771	0.00363	CcSEcCtD
Tolterodine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000766	0.00361	CcSEcCtD
Tolterodine—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000763	0.00359	CcSEcCtD
Tolterodine—Oedema—Prednisolone—multiple sclerosis	0.000763	0.00359	CcSEcCtD
Tolterodine—Dysuria—Methotrexate—multiple sclerosis	0.000762	0.00359	CcSEcCtD
Tolterodine—Dizziness—Azathioprine—multiple sclerosis	0.000761	0.00358	CcSEcCtD
Tolterodine—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000761	0.00358	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.000757	0.00356	CcSEcCtD
Tolterodine—Tachycardia—Prednisolone—multiple sclerosis	0.000745	0.00351	CcSEcCtD
Tolterodine—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000735	0.00346	CcSEcCtD
Tolterodine—Arthralgia—Methylprednisolone—multiple sclerosis	0.00073	0.00344	CcSEcCtD
Tolterodine—Anxiety—Methylprednisolone—multiple sclerosis	0.000728	0.00343	CcSEcCtD
Tolterodine—Flushing—Prednisone—multiple sclerosis	0.000724	0.00341	CcSEcCtD
Tolterodine—Headache—Azathioprine—multiple sclerosis	0.000721	0.00339	CcSEcCtD
Tolterodine—Dry mouth—Triamcinolone—multiple sclerosis	0.000716	0.00337	CcSEcCtD
Tolterodine—Angioedema—Dexamethasone—multiple sclerosis	0.000713	0.00336	CcSEcCtD
Tolterodine—Angioedema—Betamethasone—multiple sclerosis	0.000713	0.00336	CcSEcCtD
Tolterodine—Confusional state—Methylprednisolone—multiple sclerosis	0.000706	0.00332	CcSEcCtD
Tolterodine—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000702	0.0033	CcSEcCtD
Tolterodine—Oedema—Triamcinolone—multiple sclerosis	0.000702	0.0033	CcSEcCtD
Tolterodine—Vertigo—Dexamethasone—multiple sclerosis	0.000701	0.0033	CcSEcCtD
Tolterodine—Vertigo—Betamethasone—multiple sclerosis	0.000701	0.0033	CcSEcCtD
Tolterodine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.0007	0.0033	CcSEcCtD
Tolterodine—Infection—Triamcinolone—multiple sclerosis	0.000697	0.00328	CcSEcCtD
Tolterodine—Infection—Methylprednisolone—multiple sclerosis	0.000696	0.00327	CcSEcCtD
Tolterodine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000685	0.00323	CcSEcCtD
Tolterodine—Tachycardia—Triamcinolone—multiple sclerosis	0.000685	0.00322	CcSEcCtD
Tolterodine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000683	0.00322	CcSEcCtD
Tolterodine—Asthenia—Mitoxantrone—multiple sclerosis	0.000667	0.00314	CcSEcCtD
Tolterodine—Anxiety—Dexamethasone—multiple sclerosis	0.000662	0.00312	CcSEcCtD
Tolterodine—Anxiety—Betamethasone—multiple sclerosis	0.000662	0.00312	CcSEcCtD
Tolterodine—Pain—Prednisolone—multiple sclerosis	0.000653	0.00307	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000639	0.00301	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000638	0.003	CcSEcCtD
Tolterodine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000637	0.003	CcSEcCtD
Tolterodine—Oedema—Dexamethasone—multiple sclerosis	0.000637	0.003	CcSEcCtD
Tolterodine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000637	0.003	CcSEcCtD
Tolterodine—Oedema—Betamethasone—multiple sclerosis	0.000637	0.003	CcSEcCtD
Tolterodine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000636	0.003	CcSEcCtD
Tolterodine—Infection—Betamethasone—multiple sclerosis	0.000633	0.00298	CcSEcCtD
Tolterodine—Infection—Dexamethasone—multiple sclerosis	0.000633	0.00298	CcSEcCtD
Tolterodine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000629	0.00296	CcSEcCtD
Tolterodine—Visual impairment—Methotrexate—multiple sclerosis	0.000629	0.00296	CcSEcCtD
Tolterodine—Tachycardia—Betamethasone—multiple sclerosis	0.000621	0.00292	CcSEcCtD
Tolterodine—Tachycardia—Dexamethasone—multiple sclerosis	0.000621	0.00292	CcSEcCtD
Tolterodine—Angioedema—Prednisone—multiple sclerosis	0.000621	0.00292	CcSEcCtD
Tolterodine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000618	0.00291	CcSEcCtD
Tolterodine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000616	0.0029	CcSEcCtD
Tolterodine—Vertigo—Prednisone—multiple sclerosis	0.00061	0.00287	CcSEcCtD
Tolterodine—Fatigue—Triamcinolone—multiple sclerosis	0.000605	0.00285	CcSEcCtD
Tolterodine—Fatigue—Methylprednisolone—multiple sclerosis	0.000604	0.00284	CcSEcCtD
Tolterodine—Pain—Triamcinolone—multiple sclerosis	0.0006	0.00282	CcSEcCtD
Tolterodine—Headache—Mitoxantrone—multiple sclerosis	0.000583	0.00274	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.00058	0.00273	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.00058	0.00273	CcSEcCtD
Tolterodine—Arthralgia—Prednisone—multiple sclerosis	0.000578	0.00272	CcSEcCtD
Tolterodine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000578	0.00272	CcSEcCtD
Tolterodine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000577	0.00272	CcSEcCtD
Tolterodine—Anxiety—Prednisone—multiple sclerosis	0.000576	0.00271	CcSEcCtD
Tolterodine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000573	0.00269	CcSEcCtD
Tolterodine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000562	0.00265	CcSEcCtD
Tolterodine—Dyspepsia—Dexamethasone—multiple sclerosis	0.00056	0.00264	CcSEcCtD
Tolterodine—Dyspepsia—Betamethasone—multiple sclerosis	0.00056	0.00264	CcSEcCtD
Tolterodine—Anaphylactic shock—Prednisone—multiple sclerosis	0.000555	0.00261	CcSEcCtD
Tolterodine—Oedema—Prednisone—multiple sclerosis	0.000555	0.00261	CcSEcCtD
Tolterodine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000554	0.00261	CcSEcCtD
Tolterodine—Infection—Prednisone—multiple sclerosis	0.000551	0.00259	CcSEcCtD
Tolterodine—Fatigue—Dexamethasone—multiple sclerosis	0.000549	0.00258	CcSEcCtD
Tolterodine—Fatigue—Betamethasone—multiple sclerosis	0.000549	0.00258	CcSEcCtD
Tolterodine—Pain—Betamethasone—multiple sclerosis	0.000544	0.00256	CcSEcCtD
Tolterodine—Pain—Dexamethasone—multiple sclerosis	0.000544	0.00256	CcSEcCtD
Tolterodine—Tachycardia—Prednisone—multiple sclerosis	0.000541	0.00255	CcSEcCtD
Tolterodine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000525	0.00247	CcSEcCtD
Tolterodine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000525	0.00247	CcSEcCtD
Tolterodine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000521	0.00245	CcSEcCtD
Tolterodine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000521	0.00245	CcSEcCtD
Tolterodine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000517	0.00243	CcSEcCtD
Tolterodine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000516	0.00243	CcSEcCtD
Tolterodine—Vertigo—Methotrexate—multiple sclerosis	0.00051	0.0024	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000505	0.00238	CcSEcCtD
Tolterodine—Dizziness—Prednisolone—multiple sclerosis	0.000505	0.00238	CcSEcCtD
Tolterodine—Asthenia—Triamcinolone—multiple sclerosis	0.000503	0.00237	CcSEcCtD
Tolterodine—Abdominal pain—Dexamethasone—multiple sclerosis	0.000503	0.00237	CcSEcCtD
Tolterodine—Abdominal pain—Betamethasone—multiple sclerosis	0.000503	0.00237	CcSEcCtD
Tolterodine—Asthenia—Methylprednisolone—multiple sclerosis	0.000502	0.00236	CcSEcCtD
Tolterodine—Dyspepsia—Prednisone—multiple sclerosis	0.000488	0.0023	CcSEcCtD
Tolterodine—Arthralgia—Methotrexate—multiple sclerosis	0.000483	0.00228	CcSEcCtD
Tolterodine—Chest pain—Methotrexate—multiple sclerosis	0.000483	0.00228	CcSEcCtD
Tolterodine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000479	0.00225	CcSEcCtD
Tolterodine—Fatigue—Prednisone—multiple sclerosis	0.000478	0.00225	CcSEcCtD
Tolterodine—Headache—Prednisolone—multiple sclerosis	0.000478	0.00225	CcSEcCtD
Tolterodine—Constipation—Prednisone—multiple sclerosis	0.000474	0.00223	CcSEcCtD
Tolterodine—Confusional state—Methotrexate—multiple sclerosis	0.000467	0.0022	CcSEcCtD
Tolterodine—Dizziness—Triamcinolone—multiple sclerosis	0.000464	0.00218	CcSEcCtD
Tolterodine—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000463	0.00218	CcSEcCtD
Tolterodine—Dizziness—Methylprednisolone—multiple sclerosis	0.000463	0.00218	CcSEcCtD
Tolterodine—Infection—Methotrexate—multiple sclerosis	0.00046	0.00217	CcSEcCtD
Tolterodine—Feeling abnormal—Prednisone—multiple sclerosis	0.000457	0.00215	CcSEcCtD
Tolterodine—Asthenia—Betamethasone—multiple sclerosis	0.000457	0.00215	CcSEcCtD
Tolterodine—Asthenia—Dexamethasone—multiple sclerosis	0.000457	0.00215	CcSEcCtD
Tolterodine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000453	0.00213	CcSEcCtD
Tolterodine—Headache—Triamcinolone—multiple sclerosis	0.00044	0.00207	CcSEcCtD
Tolterodine—Headache—Methylprednisolone—multiple sclerosis	0.000439	0.00206	CcSEcCtD
Tolterodine—Abdominal pain—Prednisone—multiple sclerosis	0.000438	0.00206	CcSEcCtD
Tolterodine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000436	0.00205	CcSEcCtD
Tolterodine—Diarrhoea—Betamethasone—multiple sclerosis	0.000436	0.00205	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000422	0.00199	CcSEcCtD
Tolterodine—Dizziness—Dexamethasone—multiple sclerosis	0.000421	0.00198	CcSEcCtD
Tolterodine—Dizziness—Betamethasone—multiple sclerosis	0.000421	0.00198	CcSEcCtD
Tolterodine—Somnolence—Methotrexate—multiple sclerosis	0.000412	0.00194	CcSEcCtD
Tolterodine—Hypersensitivity—Prednisone—multiple sclerosis	0.000409	0.00192	CcSEcCtD
Tolterodine—Dyspepsia—Methotrexate—multiple sclerosis	0.000408	0.00192	CcSEcCtD
Tolterodine—Fatigue—Methotrexate—multiple sclerosis	0.0004	0.00188	CcSEcCtD
Tolterodine—Headache—Betamethasone—multiple sclerosis	0.000399	0.00188	CcSEcCtD
Tolterodine—Headache—Dexamethasone—multiple sclerosis	0.000399	0.00188	CcSEcCtD
Tolterodine—Asthenia—Prednisone—multiple sclerosis	0.000398	0.00187	CcSEcCtD
Tolterodine—Pain—Methotrexate—multiple sclerosis	0.000396	0.00187	CcSEcCtD
Tolterodine—Feeling abnormal—Methotrexate—multiple sclerosis	0.000382	0.0018	CcSEcCtD
Tolterodine—Diarrhoea—Prednisone—multiple sclerosis	0.000379	0.00179	CcSEcCtD
Tolterodine—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000379	0.00178	CcSEcCtD
Tolterodine—Dizziness—Prednisone—multiple sclerosis	0.000367	0.00173	CcSEcCtD
Tolterodine—Abdominal pain—Methotrexate—multiple sclerosis	0.000366	0.00172	CcSEcCtD
Tolterodine—Headache—Prednisone—multiple sclerosis	0.000347	0.00164	CcSEcCtD
Tolterodine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000341	0.00161	CcSEcCtD
Tolterodine—Asthenia—Methotrexate—multiple sclerosis	0.000332	0.00156	CcSEcCtD
Tolterodine—Diarrhoea—Methotrexate—multiple sclerosis	0.000317	0.00149	CcSEcCtD
Tolterodine—Dizziness—Methotrexate—multiple sclerosis	0.000306	0.00144	CcSEcCtD
Tolterodine—Headache—Methotrexate—multiple sclerosis	0.00029	0.00137	CcSEcCtD
Tolterodine—CHRM1—GPCR ligand binding—CCL2—multiple sclerosis	5.91e-05	0.000488	CbGpPWpGaD
Tolterodine—CHRM3—GPCR ligand binding—CCL2—multiple sclerosis	5.89e-05	0.000486	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—CCR5—multiple sclerosis	5.88e-05	0.000485	CbGpPWpGaD
Tolterodine—CHRM2—GPCR ligand binding—CCL2—multiple sclerosis	5.84e-05	0.000481	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	5.8e-05	0.000479	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	5.8e-05	0.000479	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—IL2RA—multiple sclerosis	5.8e-05	0.000478	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—GPC5—multiple sclerosis	5.77e-05	0.000476	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	5.75e-05	0.000475	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	5.75e-05	0.000475	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—PTGER4—multiple sclerosis	5.74e-05	0.000474	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CCL3—multiple sclerosis	5.71e-05	0.000471	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—CNR1—multiple sclerosis	5.68e-05	0.000469	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—CNR1—multiple sclerosis	5.66e-05	0.000467	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—PGR—multiple sclerosis	5.65e-05	0.000466	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CCR1—multiple sclerosis	5.64e-05	0.000466	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CXCL13—multiple sclerosis	5.64e-05	0.000466	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—CCR5—multiple sclerosis	5.64e-05	0.000465	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—CXCL10—multiple sclerosis	5.63e-05	0.000465	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CXCL13—multiple sclerosis	5.63e-05	0.000464	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CCR1—multiple sclerosis	5.63e-05	0.000464	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	5.62e-05	0.000464	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—CXCL10—multiple sclerosis	5.62e-05	0.000463	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—CNR1—multiple sclerosis	5.61e-05	0.000463	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CXCL13—multiple sclerosis	5.57e-05	0.00046	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CCR1—multiple sclerosis	5.57e-05	0.00046	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—CXCL10—multiple sclerosis	5.56e-05	0.000459	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—IL2RA—multiple sclerosis	5.55e-05	0.000458	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CXCR3—multiple sclerosis	5.55e-05	0.000457	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—PTGER4—multiple sclerosis	5.5e-05	0.000453	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CD28—multiple sclerosis	5.49e-05	0.000453	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—PGR—multiple sclerosis	5.42e-05	0.000447	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CCR2—multiple sclerosis	5.39e-05	0.000445	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—SRM—multiple sclerosis	5.39e-05	0.000444	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CXCR3—multiple sclerosis	5.31e-05	0.000438	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—GPC5—multiple sclerosis	5.31e-05	0.000438	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—GPC5—multiple sclerosis	5.26e-05	0.000434	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CD28—multiple sclerosis	5.26e-05	0.000434	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CCR2—multiple sclerosis	5.17e-05	0.000426	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—CXCL10—multiple sclerosis	5.12e-05	0.000422	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—CXCL10—multiple sclerosis	5.1e-05	0.000421	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—POMC—multiple sclerosis	5.06e-05	0.000418	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—CXCL10—multiple sclerosis	5.05e-05	0.000417	CbGpPWpGaD
Tolterodine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	4.99e-05	0.000412	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CNR1—multiple sclerosis	4.98e-05	0.000411	CbGpPWpGaD
Tolterodine—CHRM1—Circadian rythm related genes—IL6—multiple sclerosis	4.91e-05	0.000405	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—POMC—multiple sclerosis	4.85e-05	0.0004	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—CCL5—multiple sclerosis	4.85e-05	0.0004	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—CCL5—multiple sclerosis	4.83e-05	0.000399	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—CCL5—multiple sclerosis	4.79e-05	0.000395	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—RRM1—multiple sclerosis	4.78e-05	0.000394	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CNR1—multiple sclerosis	4.77e-05	0.000393	CbGpPWpGaD
Tolterodine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	4.66e-05	0.000384	CbGpPWpGaD
Tolterodine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	4.64e-05	0.000383	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—POMC—multiple sclerosis	4.6e-05	0.000379	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—CCL2—multiple sclerosis	4.5e-05	0.000371	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CXCL10—multiple sclerosis	4.48e-05	0.00037	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—POMC—multiple sclerosis	4.4e-05	0.000363	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—CCL5—multiple sclerosis	4.4e-05	0.000363	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—RRM1—multiple sclerosis	4.4e-05	0.000363	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—CCL5—multiple sclerosis	4.39e-05	0.000362	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—CCR5—multiple sclerosis	4.37e-05	0.00036	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—RRM1—multiple sclerosis	4.36e-05	0.00036	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—CCR5—multiple sclerosis	4.36e-05	0.000359	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—CCL5—multiple sclerosis	4.35e-05	0.000359	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—CCR5—multiple sclerosis	4.31e-05	0.000356	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—CCL2—multiple sclerosis	4.31e-05	0.000355	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—IL2RA—multiple sclerosis	4.31e-05	0.000355	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CXCL10—multiple sclerosis	4.29e-05	0.000354	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—IL2RA—multiple sclerosis	4.29e-05	0.000354	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—IL2RA—multiple sclerosis	4.25e-05	0.000351	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—BCHE—multiple sclerosis	4.23e-05	0.000349	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—TYK2—multiple sclerosis	4.09e-05	0.000337	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CCL3—multiple sclerosis	4.02e-05	0.000332	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CCL3—multiple sclerosis	4.01e-05	0.000331	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CCL3—multiple sclerosis	3.97e-05	0.000327	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—CCR5—multiple sclerosis	3.97e-05	0.000327	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—CCR5—multiple sclerosis	3.96e-05	0.000326	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CD86—multiple sclerosis	3.92e-05	0.000323	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—CCR5—multiple sclerosis	3.92e-05	0.000323	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—TYK2—multiple sclerosis	3.91e-05	0.000323	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—IL2RA—multiple sclerosis	3.91e-05	0.000323	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—IL2RA—multiple sclerosis	3.9e-05	0.000321	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PTGER4—multiple sclerosis	3.87e-05	0.000319	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—IL2RA—multiple sclerosis	3.86e-05	0.000318	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PTGER4—multiple sclerosis	3.86e-05	0.000318	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CCL5—multiple sclerosis	3.86e-05	0.000318	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PTGER4—multiple sclerosis	3.82e-05	0.000315	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PGR—multiple sclerosis	3.81e-05	0.000314	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PGR—multiple sclerosis	3.8e-05	0.000313	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	3.8e-05	0.000313	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	3.8e-05	0.000313	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PGR—multiple sclerosis	3.76e-05	0.00031	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CD86—multiple sclerosis	3.75e-05	0.00031	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—IL2—multiple sclerosis	3.74e-05	0.000309	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CXCR3—multiple sclerosis	3.74e-05	0.000308	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CXCR3—multiple sclerosis	3.73e-05	0.000307	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.71e-05	0.000306	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CD28—multiple sclerosis	3.7e-05	0.000305	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CCL5—multiple sclerosis	3.7e-05	0.000305	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CD28—multiple sclerosis	3.69e-05	0.000305	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CXCR3—multiple sclerosis	3.69e-05	0.000304	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CD28—multiple sclerosis	3.66e-05	0.000302	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CCR2—multiple sclerosis	3.64e-05	0.0003	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CCR2—multiple sclerosis	3.63e-05	0.000299	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CCR2—multiple sclerosis	3.59e-05	0.000296	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—IL2—multiple sclerosis	3.59e-05	0.000296	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—SPP1—multiple sclerosis	3.57e-05	0.000295	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CCR5—multiple sclerosis	3.48e-05	0.000287	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GPC5—multiple sclerosis	3.47e-05	0.000286	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—IL2RA—multiple sclerosis	3.43e-05	0.000283	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—SPP1—multiple sclerosis	3.42e-05	0.000282	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—POMC—multiple sclerosis	3.41e-05	0.000282	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—POMC—multiple sclerosis	3.4e-05	0.000281	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—IL2—multiple sclerosis	3.4e-05	0.00028	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.38e-05	0.000279	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—POMC—multiple sclerosis	3.37e-05	0.000278	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CNR1—multiple sclerosis	3.36e-05	0.000277	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CNR1—multiple sclerosis	3.35e-05	0.000276	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CCR5—multiple sclerosis	3.33e-05	0.000275	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CNR1—multiple sclerosis	3.31e-05	0.000273	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—IL2RA—multiple sclerosis	3.28e-05	0.000271	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—IL2—multiple sclerosis	3.26e-05	0.000269	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.19e-05	0.000263	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—APOE—multiple sclerosis	3.16e-05	0.000261	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—POMC—multiple sclerosis	3.1e-05	0.000256	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—POMC—multiple sclerosis	3.09e-05	0.000255	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—POMC—multiple sclerosis	3.06e-05	0.000252	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—CCL2—multiple sclerosis	3.03e-05	0.00025	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—APOE—multiple sclerosis	3.03e-05	0.00025	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—CCL2—multiple sclerosis	3.02e-05	0.000249	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CXCL10—multiple sclerosis	3.02e-05	0.000249	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CXCL10—multiple sclerosis	3.01e-05	0.000248	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—CCL2—multiple sclerosis	3e-05	0.000247	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CXCL10—multiple sclerosis	2.98e-05	0.000246	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.91e-05	0.00024	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.91e-05	0.00024	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—RRM1—multiple sclerosis	2.88e-05	0.000237	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CD80—multiple sclerosis	2.86e-05	0.000236	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—TYK2—multiple sclerosis	2.76e-05	0.000227	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—BCHE—multiple sclerosis	2.75e-05	0.000227	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—TYK2—multiple sclerosis	2.75e-05	0.000227	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CD80—multiple sclerosis	2.74e-05	0.000226	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—TYK2—multiple sclerosis	2.72e-05	0.000224	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—POMC—multiple sclerosis	2.72e-05	0.000224	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CCL2—multiple sclerosis	2.66e-05	0.000219	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.65e-05	0.000219	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CD86—multiple sclerosis	2.64e-05	0.000218	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CD86—multiple sclerosis	2.63e-05	0.000217	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CD86—multiple sclerosis	2.61e-05	0.000215	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—POMC—multiple sclerosis	2.6e-05	0.000215	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CCL5—multiple sclerosis	2.6e-05	0.000215	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—MAPK1—multiple sclerosis	2.6e-05	0.000214	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CCL5—multiple sclerosis	2.59e-05	0.000214	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CCL5—multiple sclerosis	2.57e-05	0.000212	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CCL2—multiple sclerosis	2.55e-05	0.00021	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—APOE—multiple sclerosis	2.54e-05	0.00021	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—BCHE—multiple sclerosis	2.53e-05	0.000208	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—IL2—multiple sclerosis	2.52e-05	0.000208	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—IL2—multiple sclerosis	2.52e-05	0.000208	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—BCHE—multiple sclerosis	2.5e-05	0.000207	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—IL2—multiple sclerosis	2.49e-05	0.000206	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—MAPK1—multiple sclerosis	2.49e-05	0.000205	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—TYK2—multiple sclerosis	2.41e-05	0.000199	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—SPP1—multiple sclerosis	2.41e-05	0.000199	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—SPP1—multiple sclerosis	2.4e-05	0.000198	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—SPP1—multiple sclerosis	2.38e-05	0.000196	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CCR5—multiple sclerosis	2.34e-05	0.000193	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CCR5—multiple sclerosis	2.34e-05	0.000193	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CCR5—multiple sclerosis	2.31e-05	0.000191	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—TYK2—multiple sclerosis	2.31e-05	0.000191	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IL2RA—multiple sclerosis	2.31e-05	0.000191	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IL2RA—multiple sclerosis	2.3e-05	0.00019	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—IL2—multiple sclerosis	2.29e-05	0.000189	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—IL2—multiple sclerosis	2.29e-05	0.000188	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IL2RA—multiple sclerosis	2.28e-05	0.000188	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—IL2—multiple sclerosis	2.26e-05	0.000187	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—POMC—multiple sclerosis	2.18e-05	0.00018	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—APOE—multiple sclerosis	2.13e-05	0.000176	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—APOE—multiple sclerosis	2.13e-05	0.000175	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—APOE—multiple sclerosis	2.11e-05	0.000174	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—IL2—multiple sclerosis	2.01e-05	0.000166	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—IL6—multiple sclerosis	2e-05	0.000165	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—ALB—multiple sclerosis	1.99e-05	0.000164	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CD80—multiple sclerosis	1.93e-05	0.000159	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—IL2—multiple sclerosis	1.92e-05	0.000159	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CD80—multiple sclerosis	1.92e-05	0.000159	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—IL6—multiple sclerosis	1.91e-05	0.000158	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CD80—multiple sclerosis	1.9e-05	0.000157	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—MMP9—multiple sclerosis	1.9e-05	0.000157	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—POMC—multiple sclerosis	1.83e-05	0.000151	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—POMC—multiple sclerosis	1.83e-05	0.000151	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—MMP9—multiple sclerosis	1.82e-05	0.00015	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—POMC—multiple sclerosis	1.81e-05	0.000149	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CCL2—multiple sclerosis	1.79e-05	0.000148	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CCL2—multiple sclerosis	1.79e-05	0.000147	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CCL2—multiple sclerosis	1.77e-05	0.000146	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—MAPK1—multiple sclerosis	1.75e-05	0.000145	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—MAPK1—multiple sclerosis	1.75e-05	0.000144	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—MAPK1—multiple sclerosis	1.73e-05	0.000143	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—STAT3—multiple sclerosis	1.69e-05	0.000139	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—APOE—multiple sclerosis	1.65e-05	0.000136	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.65e-05	0.000136	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—TYK2—multiple sclerosis	1.63e-05	0.000134	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—TYK2—multiple sclerosis	1.62e-05	0.000134	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—STAT3—multiple sclerosis	1.62e-05	0.000133	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—TYK2—multiple sclerosis	1.61e-05	0.000133	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—MYC—multiple sclerosis	1.57e-05	0.00013	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—TGFB1—multiple sclerosis	1.57e-05	0.000129	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—MAPK1—multiple sclerosis	1.54e-05	0.000127	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—APOE—multiple sclerosis	1.52e-05	0.000125	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—APOE—multiple sclerosis	1.51e-05	0.000124	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—MYC—multiple sclerosis	1.5e-05	0.000124	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—TGFB1—multiple sclerosis	1.5e-05	0.000124	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—MAPK1—multiple sclerosis	1.47e-05	0.000121	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—POMC—multiple sclerosis	1.42e-05	0.000117	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IL2—multiple sclerosis	1.35e-05	0.000112	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IL2—multiple sclerosis	1.35e-05	0.000111	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—IL6—multiple sclerosis	1.35e-05	0.000111	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—IL6—multiple sclerosis	1.34e-05	0.000111	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IL2—multiple sclerosis	1.34e-05	0.00011	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—IL6—multiple sclerosis	1.33e-05	0.00011	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—POMC—multiple sclerosis	1.31e-05	0.000108	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—POMC—multiple sclerosis	1.29e-05	0.000107	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—ALB—multiple sclerosis	1.29e-05	0.000107	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—MMP9—multiple sclerosis	1.28e-05	0.000106	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—MMP9—multiple sclerosis	1.28e-05	0.000105	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—MMP9—multiple sclerosis	1.27e-05	0.000104	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—ALB—multiple sclerosis	1.19e-05	9.82e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—IL6—multiple sclerosis	1.18e-05	9.74e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—ALB—multiple sclerosis	1.18e-05	9.73e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—STAT3—multiple sclerosis	1.14e-05	9.4e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—STAT3—multiple sclerosis	1.14e-05	9.37e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—IL6—multiple sclerosis	1.13e-05	9.32e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—STAT3—multiple sclerosis	1.12e-05	9.28e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—MYC—multiple sclerosis	1.06e-05	8.73e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—TGFB1—multiple sclerosis	1.06e-05	8.71e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—MYC—multiple sclerosis	1.06e-05	8.71e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—TGFB1—multiple sclerosis	1.05e-05	8.68e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—MYC—multiple sclerosis	1.05e-05	8.62e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—TGFB1—multiple sclerosis	1.04e-05	8.6e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—MAPK1—multiple sclerosis	1.04e-05	8.54e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—MAPK1—multiple sclerosis	1.03e-05	8.52e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—MAPK1—multiple sclerosis	1.02e-05	8.43e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—APOE—multiple sclerosis	9.94e-06	8.2e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—POMC—multiple sclerosis	8.54e-06	7.04e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IL6—multiple sclerosis	7.96e-06	6.57e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IL6—multiple sclerosis	7.93e-06	6.54e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IL6—multiple sclerosis	7.86e-06	6.48e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—ALB—multiple sclerosis	7.78e-06	6.42e-05	CbGpPWpGaD
